MT Newswires
B. Riley Adjusts Price Target on Capricor Therapeutics to $63 From $50, Maintains Buy Rating
📈
AI Sentiment
Highly Positive
8/10
Capricor Therapeutics Inc. News
Latest updates and market news for CAPR
8 news
Mar 12 - Mar 18, 2026
Page 1
GuruFocus.com
Capricor Therapeutics Inc (CAPR) Q4 2025 Earnings Call Highlights: FDA Milestones and Financial ...
📊
AI Sentiment
Positive
7/10
Associated Press Finance
Capricor: Q4 Earnings Snapshot
GlobeNewswire
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
📈
AI Sentiment
Highly Positive
9/10
Share this news page